GENE ONLINE|News &
Opinion
Blog

Ofatumumab
Trials & Approvals Multiple Sclerosis
Novartis’ Kesimpta Notches FDA Approval as Targeted B-cell Therapy for Patients with Relapsing MS
2020-08-23
R&D Multiple Sclerosis
Novartis Reveals Positive Ofatumumab Data for Treating Relapsing Forms of Multiple sclerosis
2020-06-07
LATEST
Orlando Sales Firm Seeks Pharmaceutical Sales Professionals for Entry-Level Roles in Alafaya
2025-06-18
AstraZeneca Hiring Primary Care Pharmaceutical Sales Specialists for National Sales Network in US
2025-06-18
Eli Lilly Announces Associate Territory Manager Opening in Cardiometabolic Health Division for Washington, D.C.
2025-06-18
Alcon Vision Company Hiring Remote Pharmaceutical Sales Specialist in Chicago Region
2025-06-18
Gilead Sciences Reports Promising CAR-T Therapy Results for Glioblastoma Treatment
2025-06-18
Merck Offers Over $3 Billion to Acquire MoonLake Immunotherapeutics Amid Biotech Sector Challenges
2025-06-18
Study Links GLP-1 Drugs to Increased Risk of Diabetic Retinopathy and Vision Loss
2025-06-18
READ MORE
EVENT
2025-06-16
US BIO International Convention
Boston, U.S.A.
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2025 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top